Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Pharmacogenomics of Antiplatelet Response - I

Trial Profile

Pharmacogenomics of Antiplatelet Response - I

Phase of Trial: Phase IV

Latest Information Update: 11 Jan 2017

At a glance

  • Drugs Aspirin (Primary) ; Clopidogrel (Primary)
  • Indications Coronary artery disease; Myocardial infarction; Stroke; Thrombosis
  • Focus Pharmacodynamics; Pharmacogenomic
  • Acronyms PARes-I
  • Most Recent Events

    • 31 Aug 2018 Biomarkers information updated
    • 28 Mar 2013 Additional information taken from trial website.
    • 28 Mar 2013 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top